scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1042528582 |
P356 | DOI | 10.1007/BF02968045 |
P698 | PubMed publication ID | 15604993 |
P2093 | author name string | Mamoru Fukuda | |
Satoru Shimizu | |||
Takashi Suda | |||
Takashi Ishikawa | |||
Yutaka Tokuda | |||
Akira Ishiyama | |||
Hiroshi Shimada | |||
Eisuke Fukuma | |||
Masaaki Inaba | |||
Kazuo Ishida | |||
Yohei Hamaguchi | |||
Taro Asaga | |||
Kanagawa Breast Cancer Treatment Society (KBCTS) | |||
Kiyohumi Katayama | |||
P2860 | cites work | Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens | Q35976425 |
A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer | Q36134486 | ||
A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC. European Organization for Research and Treatment of Cancer | Q36135843 | ||
P433 | issue | 4 | |
P921 | main subject | docetaxel | Q420436 |
P304 | page(s) | 374-379 | |
P577 | publication date | 2004-01-01 | |
P1433 | published in | Breast Cancer | Q15752871 |
P1476 | title | A multicenter phase II study of docetaxel 60 mg/m2 as first-line chemotherapy in patients with advanced or recurrent breast cancer | |
P478 | volume | 11 |
Search more.